Back
Perspective Therapeutics Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
48
CATX
Perspective Therapeutics
Last Price:
$2.6700
Seasonality Move:
0.1%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.37 | Buy |
| 20-day SMA: | 2.35 | Buy |
| 50-day SMA: | 2.29 | Buy |
| 200-day SMA: | 6.91 | Sell |
| 8-day EMA: | 2.38 | Buy |
| 20-day EMA: | 2.34 | Buy |
| 50-day EMA: | 2.47 | Sell |
| 200-day EMA: | 5.4 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 52.43 | Buy |
| Chaikin Money Flow: | 501768 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.0484 - 2.4884) | Buy |
| Bollinger Bands (100): | (2.1877 - 3.3077) | Sell |
Perspective Therapeutics Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.4100 while CATX 8-day simple moving average is 2.3738, which is a Buy signal.
-
The stock price of CATX is 2.4100 while Perspective Therapeutics 20-day SMA is 2.3455, which makes it a Buy.
-
Perspective Therapeutics 50-day simple moving average is 2.2884 while CATX share price is 2.4100, making it a Buy technically.
-
CATX stock price is 2.4100 and Perspective Therapeutics 200-day simple moving average is 6.9106, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
48
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a SellThe current Perspective Therapeutics [CATX] share price is $2.4100. The Score for CATX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
178.9M
Price in USD:
2.4100
Share Volume:
570.6K
Perspective Therapeutics 52-Week Range
52-Week High:
16.9000
52-Week Low:
1.6000
Sell
48
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?The Perspective Therapeutics stock price is 2.4100 USD today.
-
Will CATX stock go up or go down?Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Perspective Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.4100 while CATX 8-day exponential moving average is 2.3822, which is a Buy signal.
-
The stock price of CATX is 2.4100 while Perspective Therapeutics 20-day EMA is 2.3390, which makes it a Buy.
-
Perspective Therapeutics 50-day exponential moving average is 2.4706 while CATX share price is 2.4100, making it a Sell technically.
-
CATX stock price is 2.4100 and Perspective Therapeutics 200-day simple moving average is 5.3951, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
-
CATX Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Perspective Therapeutics is a Buy
-
Perspective Therapeutics Relative Strength Index (RSI) is 52.43, which suggest Perspective Therapeutics is overbought
-
The Bollinger Bands (25) for Perspective Therapeutics is (2.0484 - 2.4884), which suggest Perspective Therapeutics is a Sell
-
The Bollinger Bands (100) for Perspective Therapeutics is (2.1877 - 3.3077), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.